Carlos J Rosado
Over the past decade, I have worked on deciphering the mechanism of signalling through the Receptor for Advanced Glycation End-Products (RAGE) and its role in diabetes and disease. This has culminated in a co-first author JCI paper describing a novel transactivation pathway for RAGE and associated proteins. His work has led to the generation of three patents in this space. I have worked on the delivery of peptides and DNA into the cell, and release of cargo to act as therapeutics targeting inflammation and proliferation. I have published in a range of journals including Kidney International, Science, Autophagy, Nature Communications.
Abstracts this author is presenting:
